Cue Biopharma, Inc.

NASDAQ:CUE

Biotechnology

Healthcare
$14.10 +1.42%

+$0.38 today

Market cap
$102.43M
Beta
2.53
P/E (TTM)
-6.7
EPS (TTM)
-$4.06
52W Low $4.98High $41.42

Volume 0.21M

Average 0.74M

Balance Sheet

Inspect the capital base behind the business.

Assets

$42.21M

FY 2025 · Annual

+31.1% YoY

Liabilities

$15.78M

FY 2025 · Annual

+7.4% YoY

Equity

$26.43M

FY 2025 · Annual

+51.0% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents64.37M51.61M48.51M22.46M27.14M
Short-term Investments024.68M0929K0
Net Receivables3.14M57K1.7M945K7.45M
Inventory00000
Other Current Assets80K841K1.24M805K2.4M
Total Current Assets68.47M77.19M51.45M25.14M36.98M
Property, Plant & Equipment (Net)11.92M10.7M7.12M4.84M4.32M
Goodwill00000
Intangible Assets00000
Long-term Investments150K0151K0154K
Tax Assets00000
Other Non-current Assets2.86M3.39M2.81M2.21M760K
Total Non-current Assets14.93M14.1M10.08M7.05M5.23M
Total Assets83.4M91.28M61.53M32.19M42.21M
Account Payables2.59M2.73M3.5M2.82M3.95M
Short-term Debt1.97M1.96M3.96M4.33M0
Tax Payables00000
Deferred Revenue645.35K02.11M05.34M
Other Current Liabilities38.31K2.27M1.92M85K783K
Total Current Liabilities12.79M11.55M17.08M13.69M13.49M
Long-term Debt08.04M4.2M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00010
Total Non-current Liabilities5.12M14.05M7.36M1M2.29M
Total Liabilities17.91M25.6M24.45M14.69M15.78M
Common Stock32.2K43K47K62K97K
Retained Earnings(197.45M)(250.46M)(301.19M)(341.86M)(368.47M)
Accumulated OCI0(96K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity65.49M65.68M37.09M17.5M26.43M
Total Debt12.02M19.32M14.7M8.88M4.2M
Net Debt(52.35M)(32.3M)(33.82M)(13.58M)(22.94M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$16.4M
Receivables$5.4M
Other Current$4.7M
Total Current Assets$26.4M
PP&E (Net)$3.6M
Long-term Investments$154.0K
Other Non-current$725.0K
Total Non-current Assets$4.5M
Total Assets$30.9M

Analysis

Selected assets total $30.9M for Latest. The largest visible component is Cash & Equivalents at $16.4M, about 53.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 10, 2026
4Statement of changes in beneficial ownershipOct 14, 2026
4Statement of changes in beneficial ownershipOct 14, 2026
4Statement of changes in beneficial ownershipOct 14, 2026
SC 13G/ASC 13G/A filingOct 8, 2026

How much cash does CUE have?

Cue Biopharma, Inc. (CUE) reported $27.14M in cash and equivalents in fiscal 2025.

How much debt does CUE carry?

Cue Biopharma, Inc. (CUE) reported $4.20M of total debt, with net debt of -$22.94M.